2017 Completed Clinical Trials Whitepaper

Status Quo or No?

As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this analysis.

This year’s metric is comparable to what was reported for 2016 completions (3,420 trials) and for 2015 (3,028 trials). At the therapeutic area level, 2017 completed trials in oncology again dominated, with 910 trials, and type 2 diabetes was the disease with the largest number of completed trials, at 171. Who surpassed Novartis to become the top sponsor in 2017? As was reported for the previous year, 2017 also saw a significant volume of industry partnering for trials. Download now to find out more!

Download whitepaper

Next steps

Request a Demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 212-600-3520
UK & Europe : +44 (20) 805 20700

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

2017 Completed Trials

Status Quo or No?

Next steps

This is Contactus Section

Request a Demo

How can we help you?

Pharma Report Store

Datamonitor Healthcare: data analysis and insight

Citeline

Pharmaprojects: track pharma R&D

2017 Completed Trials

Status Quo or No?

Next steps

This is Contactus Section

Request a Demo

How can we help you?

Pharma Report Store

Related Products

Datamonitor Healthcare: data analysis and insight

Citeline

Pharmaprojects: track pharma R&D